Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary

<p>Abstract</p> <p>Background</p> <p>Patients with cancer of unknown primary account for 10% of patients with metastatic spinal cord compression (MSCC). This retrospective study was performed to identify prognostic factors for functional outcome, local control of MSCC,...

Full description

Bibliographic Details
Main Authors: Douglas Sarah, Huttenlocher Stefan, Bajrovic Amira, Rudat Volker, Schild Steven E, Rades Dirk
Format: Article
Language:English
Published: BMC 2012-06-01
Series:BMC Cancer
Subjects:
Online Access:http://www.biomedcentral.com/1471-2407/12/261
_version_ 1811298967987683328
author Douglas Sarah
Huttenlocher Stefan
Bajrovic Amira
Rudat Volker
Schild Steven E
Rades Dirk
author_facet Douglas Sarah
Huttenlocher Stefan
Bajrovic Amira
Rudat Volker
Schild Steven E
Rades Dirk
author_sort Douglas Sarah
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Patients with cancer of unknown primary account for 10% of patients with metastatic spinal cord compression (MSCC). This retrospective study was performed to identify prognostic factors for functional outcome, local control of MSCC, and survival in 175 of such patients treated with radiotherapy alone.</p> <p>Methods</p> <p>Investigated were nine potential prognostic factors including age, gender, Eastern Cooperative Oncology Group performance score (ECOG-PS), number of involved vertebrae, pre-radiotherapy ambulatory status, other bone metastases, visceral metastases, time developing motor deficits before radiotherapy, and the radiation schedule.</p> <p>Results</p> <p>On multivariate analysis, better functional outcome was associated with absence of visceral metastases (estimate: 0.72; 95%-confidence interval [CI]: 0.07-1.36; p = 0.030) and a slower (>7 days) development of motor deficits (estimate: 1.93; 95%-CI: 1.18-2.68; p < 0.001). Improved local control of MSCC was associated with absence of visceral metastases (risk ratio [RR]: 10.26; 95%-CI: 2.11-74.73; p = 0.004). Improved survival was associated with favorable ECOG-PS (RR: 2.12; 95%-CI: 1.40-3.29; p < 0.001), being ambulatory prior to radiotherapy (RR: 1.98; 95%-CI: 1.40-2.81; p < 0.001), absence of visceral metastases (RR: 2.74; 95%-CI: 1.93-3.91; p < 0.001), and slower development of motor deficits (RR: 1.27; 95%-CI: 1.07-1.51; p = 0.007). Absence of other bone metastases showed a trend (RR: 1.38; 95%-CI: 0.98-1.95; p = 0.07).</p> <p>Conclusions</p> <p>This study identified additional independent prognostic factors for functional outcome, local control of MSCC, and survival after radiotherapy of MSCC from cancer of unknown primary. These prognostic factors can help select the best treatment regimen for each individual patient.</p>
first_indexed 2024-04-13T06:28:05Z
format Article
id doaj.art-5bcb2000c0614d53909003349c080178
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-04-13T06:28:05Z
publishDate 2012-06-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-5bcb2000c0614d53909003349c0801782022-12-22T02:58:18ZengBMCBMC Cancer1471-24072012-06-0112126110.1186/1471-2407-12-261Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primaryDouglas SarahHuttenlocher StefanBajrovic AmiraRudat VolkerSchild Steven ERades Dirk<p>Abstract</p> <p>Background</p> <p>Patients with cancer of unknown primary account for 10% of patients with metastatic spinal cord compression (MSCC). This retrospective study was performed to identify prognostic factors for functional outcome, local control of MSCC, and survival in 175 of such patients treated with radiotherapy alone.</p> <p>Methods</p> <p>Investigated were nine potential prognostic factors including age, gender, Eastern Cooperative Oncology Group performance score (ECOG-PS), number of involved vertebrae, pre-radiotherapy ambulatory status, other bone metastases, visceral metastases, time developing motor deficits before radiotherapy, and the radiation schedule.</p> <p>Results</p> <p>On multivariate analysis, better functional outcome was associated with absence of visceral metastases (estimate: 0.72; 95%-confidence interval [CI]: 0.07-1.36; p = 0.030) and a slower (>7 days) development of motor deficits (estimate: 1.93; 95%-CI: 1.18-2.68; p < 0.001). Improved local control of MSCC was associated with absence of visceral metastases (risk ratio [RR]: 10.26; 95%-CI: 2.11-74.73; p = 0.004). Improved survival was associated with favorable ECOG-PS (RR: 2.12; 95%-CI: 1.40-3.29; p < 0.001), being ambulatory prior to radiotherapy (RR: 1.98; 95%-CI: 1.40-2.81; p < 0.001), absence of visceral metastases (RR: 2.74; 95%-CI: 1.93-3.91; p < 0.001), and slower development of motor deficits (RR: 1.27; 95%-CI: 1.07-1.51; p = 0.007). Absence of other bone metastases showed a trend (RR: 1.38; 95%-CI: 0.98-1.95; p = 0.07).</p> <p>Conclusions</p> <p>This study identified additional independent prognostic factors for functional outcome, local control of MSCC, and survival after radiotherapy of MSCC from cancer of unknown primary. These prognostic factors can help select the best treatment regimen for each individual patient.</p>http://www.biomedcentral.com/1471-2407/12/261Prognostic factorsCancer of unknown primaryMetastatic spinal cord compressionRadiotherapytreatment outcomes
spellingShingle Douglas Sarah
Huttenlocher Stefan
Bajrovic Amira
Rudat Volker
Schild Steven E
Rades Dirk
Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary
BMC Cancer
Prognostic factors
Cancer of unknown primary
Metastatic spinal cord compression
Radiotherapy
treatment outcomes
title Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary
title_full Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary
title_fullStr Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary
title_full_unstemmed Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary
title_short Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary
title_sort prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary
topic Prognostic factors
Cancer of unknown primary
Metastatic spinal cord compression
Radiotherapy
treatment outcomes
url http://www.biomedcentral.com/1471-2407/12/261
work_keys_str_mv AT douglassarah prognosticfactorsfordifferentoutcomesinpatientswithmetastaticspinalcordcompressionfromcancerofunknownprimary
AT huttenlocherstefan prognosticfactorsfordifferentoutcomesinpatientswithmetastaticspinalcordcompressionfromcancerofunknownprimary
AT bajrovicamira prognosticfactorsfordifferentoutcomesinpatientswithmetastaticspinalcordcompressionfromcancerofunknownprimary
AT rudatvolker prognosticfactorsfordifferentoutcomesinpatientswithmetastaticspinalcordcompressionfromcancerofunknownprimary
AT schildstevene prognosticfactorsfordifferentoutcomesinpatientswithmetastaticspinalcordcompressionfromcancerofunknownprimary
AT radesdirk prognosticfactorsfordifferentoutcomesinpatientswithmetastaticspinalcordcompressionfromcancerofunknownprimary